Status:
WITHDRAWN
Erythropoietin Effects After Traumatic Brain Injury
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
To determine if the early administration of erythropoietin to patients sustaining traumatic brain injury will reduce secondary brain injury.
Detailed Description
Traumatic brain injury occurs with alarming frequency in the United States and is associated with significant morbidity, mortality and economic as well as emotional consequences. Since the initial tra...
Eligibility Criteria
Inclusion
- Age \> 17, Head CT shows intracranial hemorrhage \< 6 hours after injury, GCS\<13 consented
Exclusion
- nonsurvivable injuries for more then 48 hours, CPR in the field, patients already on erythropoietin
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00260052
Start Date
July 1 2003
End Date
January 1 2010
Last Update
August 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert Hospital
Milwaukee, Wisconsin, United States, 53226